Showing results (71-80 of 3,991) with videos related to

Sort By:
Pageof 400
Journal of the American Society of Nephrology : JASN|March 1, 1992
The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysisF Lauster, H J Fülle, R Gerzer, et al.
Mineral and Electrolyte Metabolism|January 1, 1982
Dialysis treatment of acute chromium intoxication and comparative efficacy of peritoneal versus hemodialysis in chromium removalH Schiffl, P Weidmann, M Weiss, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2001
Effects of ultrapure dialysis fluid on nutritional status and inflammatory parametersH Schiffl, S M Lang, D Stratakis, et al.
Klinische Wochenschrift|August 3, 1981
Relationship between plasma catecholamines and urinary catecholamine excretion rates in normal subjects and certain diseased statesH Schiffl, P Weidmann, A Meier, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|June 5, 1999
Characterization of subtypes of hypertension in CAPD patients by cyclic guanosine monophosphateS M Lang, G Wolfram, R Gerzer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 2000
Clinical manifestations of AB-amyloidosis: effects of biocompatibility and fluxH Schiffl, R Fischer, S M Lang, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 31, 2001
Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factorsS M Lang, A Bergner, M Töpfer, et al.
Cell and Tissue Research|August 22, 2001
Hyaluronan fragments induce the synthesis of MCP-1 and IL-8 in cultured human peritoneal mesothelial cellsB Haslinger, S Mandl-Weber, A Sellmayer, et al.
Schweizerische Medizinische Wochenschrift|June 29, 1985
[Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]H Schiffl, P Weidmann, C Fragiacomo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1995
Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysisT Schulz, H Schiffl, R Scheithe, et al.
Pageof 400